The immunotherapy OST-HER2 combined with palliative radiation has shown positive data in preventing or delaying amputation ...

This type of tumor in dogs is extremely aggressive and spreads quickly. However, sometimes melanomas can also be treated with ...

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor ...

The therapy has been conditionally approved for canine osteosarcoma and is the subject of an upcoming movie, "Shelter Me: The Cancer Pioneers," which explores comparative oncology. With the ...

(RTTNews) - OS Therapies Inc. (OSTX) Thursday announced positive data for OST-HER2 in combination with palliative radiation in dogs with unresected appendicular osteosarcoma. Results from the ...

OS Therapies (OSTX) announced data in the prevention or delay of amputation during the treatment of primary osteosarcoma for OST-HER2 combined ...

New unpublished research shows that when combined with palliative radiation, OST-HER2 has had a significant impact on dogs with unresected, primary osteosarcoma. Out of 15 dogs treated ...

The therapy has been conditionally approved for canine osteosarcoma and is the subject of an upcoming movie, "Shelter Me: The Cancer Pioneers," which explores comparative oncology. With the company’s ...